These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17927010)

  • 1. Role of insulin in type 2 diabetes.
    Joshi SR
    J Assoc Physicians India; 2007 Jul; 55 Suppl():41-3. PubMed ID: 17927010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M; Orsini-Federici M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options for type 2 diabetes. Finding what's best for you.
    Clark W
    Diabetes Self Manag; 2002; 19(3):6-10, 13. PubMed ID: 12091971
    [No Abstract]   [Full Text] [Related]  

  • 5. Type 2 diabetes: the role of insulin.
    Brunton S; Carmichael B; Funnell M; Lorber D; Rakel R; Rubin R
    J Fam Pract; 2005 May; 54(5):445-52. PubMed ID: 15865903
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes.
    Bermúdez V; Cano R; Cano C; Bermúdez F; Leal E; Acosta K; Mengual E; Arraiz N; Briceño C; Gómez J; Bustamante M; Aparicio D; Cabrera M; Valdelamar L; Rodriguez M; Manuel V; Hernández R
    Am J Ther; 2008; 15(4):409-16. PubMed ID: 18645347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications for a favourable effect of intensive insulin therapy for newly-diagnosed type 2 diabetes].
    Roep BO; Pijl H
    Ned Tijdschr Geneeskd; 2008 Nov; 152(44):2378-80. PubMed ID: 19055134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical perspectives in type 2 diabetes care: optimizing glycemic control with insulin therapy.
    Diabetes Educ; 2005; Suppl():1-14; quiz 15-6. PubMed ID: 15786628
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin therapy for type 2 diabetes.
    Pergallo-Dittko V
    Diabetes Self Manag; 2003; 20(5):17, 21, 23-4. PubMed ID: 14679948
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetes mellitus: pathogenesis and treatment strategies.
    Skyler JS
    J Med Chem; 2004 Aug; 47(17):4113-7. PubMed ID: 15293979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intensification of insulin therapy in type 2 diabetics].
    Davidson JA
    Journ Annu Diabetol Hotel Dieu; 2007; ():85-8. PubMed ID: 18610760
    [No Abstract]   [Full Text] [Related]  

  • 13. When oral agents fail: optimizing insulin therapy in the older adult.
    Meece J
    Consult Pharm; 2009 Jun; 24 Suppl B():11-7. PubMed ID: 19555131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the pharmacotherapeutic options for treating type 2 diabetes.
    Kruger DF
    Diabetes Educ; 2008; 34 Suppl 3():60S-65S. PubMed ID: 18525066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes.
    Gredal C; Rosenfalck A; Dejgaard A; Hilsted J
    Diabetes Res Clin Pract; 2008 May; 80(2):293-8. PubMed ID: 18304675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting.
    Hahr AJ; Molitch ME
    Am J Ther; 2008; 15(6):543-50. PubMed ID: 19127139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin therapy in type 2 diabetes.
    Wyne KL; Mora PF
    Endocr Res; 2007; 32(3):71-107. PubMed ID: 18092196
    [No Abstract]   [Full Text] [Related]  

  • 20. A checklist approach to selecting the optimal treatment regimen for a patient with type 2 diabetes.
    Peterson GE
    J Fam Pract; 2009 Sep; 58(9 Suppl Treating):S21-5. PubMed ID: 19744421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.